Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.59 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | THRA | P10827 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.47 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.47 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23729446 | 0.98 | CASP2 (0.56) | CASP2NAAAKDM4ENPC1ALDH1A1 | |
| SCHEMBL24412633 | 0.95 | CASP2 (0.65) | CASP2NAAAKDM4EFAAHUSP2 | |
| SCHEMBL24412952 | 0.95 | CASP2 (0.65) | CASP2NAAAKDM4EFAAHUSP2 | |
| SCHEMBL24412969 | 0.94 | TP53 (0.51) | CASP2NAAAALDH1A1TP53SMN1; SMN2 | |
| SCHEMBL24412716 | 0.91 | CASP2 (0.59) | CASP2NAAAKDM4EALDH1A1FAAH | |
| SCHEMBL8437935 | 0.89 | FAAH (0.55) | CASP2NAAAKDM4ENPC1ALDH1A1 | |
| SCHEMBL8124655 | 0.88 | PAOX (0.50) | CASP2KDM4ETP53SMN1; SMN2PAOX | |
| SCHEMBL17817099 | 0.88 | KDM4E (0.62) | CASP2NAAAKDM4EALDH1A1FAAH | |
| SCHEMBL24444639 | 0.87 | CASP2 (0.54) | CASP2NAAAKDM4EFAAHUSP2 | |
| SCHEMBL20998566 | 0.86 | USP2 (0.56) | CASP2NAAAKDM4ENPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4001265-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | Shaoxing Ruikang Biotechnologies Co., Inc (CN) | 2022-05-25 | — | — | EP | disclosed |
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | SHAOXING RUIKANG BIOTECHNOLOGIES CO INC (CN) | 2022-05-12 | — | — | US | disclosed |
| EP-2403838-B1 | COMPOSITIONS CONTAINING AMIDE SURFACTANTS AND METHODS FOR INHIBITING THE FORMATION OF HYDRATE AGGLOMERATES | NALCO CO (US) | 2016-04-27 | — | — | EP | disclosed |
| US-9212305-B2 | Compositions for inhibiting the formation of hydrate agglomerates | NALCO COMPANY (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212305-B2 | Compositions for inhibiting the formation of hydrate agglomerates | NALCO COMPANY (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212305-B2 | Compositions for inhibiting the formation of hydrate agglomerates | NALCO COMPANY (US) | 2015-12-15 | — | — | US | disclosed |
| CN-102341377-B | Amide surfactant-containing compositions and methods for inhibiting hydrate agglomerate formation | NALCO CO | 2014-07-02 | — | — | CN | disclosed |
| US-8288323-B2 | Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates | NALCO COMPANY (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288323-B2 | Compositions containing amide surfactants and methods for inhibiting the formation of hydrate agglomerates | NALCO COMPANY (US) | 2012-10-16 | — | — | US | disclosed |
| CN-102341377-A | Amide surfactant-containing compositions and methods for inhibiting hydrate agglomerate formation | NALCO CO | 2012-02-01 | — | — | CN | disclosed |
| US-20100222239-A1 | COMPOSITIONS CONTAINING AMIDE SURFACTANTS AND METHODS FOR INHIBITING THE FORMATION OF HYDRATE AGGLOMERATES | APERGY ESP SYSTEMS, LLC | 2010-09-02 | — | — | US | disclosed |
| US-20100222239-A1 | COMPOSITIONS CONTAINING AMIDE SURFACTANTS AND METHODS FOR INHIBITING THE FORMATION OF HYDRATE AGGLOMERATES | APERGY ESP SYSTEMS, LLC | 2010-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100222239-A1 | COMPOSITIONS CONTAINING AMIDE SURFACTANTS AND METHODS FOR INHIBITING THE FORMATION OF HYDRATE AGGLOMERATES | AQP1, AQP3, HDHD5 | CASP2 2585/4885NAAA 24/4885KDM4E 4659/4885 |
| US-20220145045-A1 | STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF | PCNA, NCL, PNN | CASP2 4043/4885NAAA 172/4885KDM4E 1550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.